Average Ratings 0 Ratings
Average Ratings 0 Ratings
Description
BenevolentAI is a pioneering platform that leverages artificial intelligence and scientific technology to enhance drug discovery processes, specifically targeting complex diseases by efficiently processing and interpreting extensive biomedical data to yield actionable insights more swiftly than conventional approaches. By utilizing its unique Benevolent Platform, the company seamlessly integrates both structured and unstructured biomedical information—spanning literature, genomics, clinical data, and multi-omics—into a detailed knowledge graph. This robust framework empowers researchers to analyze biological systems, formulate testable hypotheses, identify new drug targets, and create potential drug candidates with increased confidence and reduced failure rates, ultimately transforming the landscape of medicine development. With its innovative approach, BenevolentAI stands at the forefront of a new era in the pharmaceutical industry.
Description
In today's business landscape, the true worth of most companies lies in their innovative concepts and the effectiveness of their execution. The ability to innovate and safeguard intellectual property is vital for the longevity and success of businesses. However, a significant number of organizations continue to rely on outdated methods such as spreadsheets, file folders, banker boxes, emails, or ineffective tools for tracking their assets. This reliance leads to inefficiencies, lost resources, unrealized potential, and heightened risk. Decipher offers a subscription-based Software-as-a-Service (SaaS) solution specifically designed for managing intellectual property. It serves as a centralized, secure platform that facilitates connections among your organization’s inventors, managers, and executives, ensuring access to essential information. Decipher simplifies the process for engineers, scientists, and other contributors to submit their innovative ideas for evaluation. For instance, if a scientist in a biotech company discovers a new molecule that may lead to a treatment for a disease, they can quickly utilize our software to enter their idea and submit it. This action not only safeguards the idea as valuable knowledge but also streamlines the review process, ensuring that no valuable insights are overlooked. By opting for modern solutions like Decipher, companies can enhance their ability to innovate while minimizing risks associated with traditional tracking methods.
API Access
Has API
API Access
Has API
Integrations
No details available.
Integrations
No details available.
Pricing Details
No price information available.
Free Trial
Free Version
Pricing Details
No price information available.
Free Trial
Free Version
Deployment
Web-Based
On-Premises
iPhone App
iPad App
Android App
Windows
Mac
Linux
Chromebook
Deployment
Web-Based
On-Premises
iPhone App
iPad App
Android App
Windows
Mac
Linux
Chromebook
Customer Support
Business Hours
Live Rep (24/7)
Online Support
Customer Support
Business Hours
Live Rep (24/7)
Online Support
Types of Training
Training Docs
Webinars
Live Training (Online)
In Person
Types of Training
Training Docs
Webinars
Live Training (Online)
In Person
Vendor Details
Company Name
BenevolentAI
Founded
2013
Country
Luxembourg
Website
www.benevolent.com
Vendor Details
Company Name
Decipher IP
Founded
2002
Country
United States
Website
decipherip.com
Product Features
Product Features
Intellectual Property Management
Deadline Management
Docket Management
Document Management
IP Portfolio Management
Information Disclosure Management
Patent Tracking
Renewal Management
Spend Management
Trademark Tracking